APA (7th ed.) Citation

F, R., C, B., S, B., A, D., Y, M., S, M., . . . S, N. (2026). BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia. Annals of hematology, 105(1), 32. https://doi.org/10.1007/s00277-026-06773-z

Chicago Style (17th ed.) Citation

F, Robert, et al. "BCOR Mutations Define a Therapeutic Vulnerability to DHODH Inhibition in Acute Myeloid Leukemia." Annals of Hematology 105, no. 1 (2026): 32. https://doi.org/10.1007/s00277-026-06773-z.

MLA (9th ed.) Citation

F, Robert, et al. "BCOR Mutations Define a Therapeutic Vulnerability to DHODH Inhibition in Acute Myeloid Leukemia." Annals of Hematology, vol. 105, no. 1, 2026, p. 32, https://doi.org/10.1007/s00277-026-06773-z.